• Quotient completes Bioanalytical Facility
    Expansion at Fordham

News & Views

Quotient completes Bioanalytical Facility

Oct 17 2012

Quotient Bioresearch, a provider of early stage and specialist drug development services, has finished the £1.5m expansion to its Fordham, Cambridgeshire site.
The building work, which took place over the summer includes a new bioanalytical facility with a capacity for 30 mass spectrometers and new laboratories for immunoassay and cell-based work with biopharmaceuticals and biomarkers.


Dr Steve Pleasance, Managing Director of Bioanalytical Sciences at Quotient commented: “Our new facilities at Fordham will assist the continued growth of our services, supporting our customers in taking new and innovative approaches. I’d like to thank all those involved in delivering the project on time and on budget. This is a big step forward for Quotient and we’re all very excited about how it will expand our offering to our clients.”


Over 60 delegates attended a series of presentations and participated in lively debate during Quotients’s Autumn Seminar on Biomarkers and Decision-Making in Drug Development, held at the new facility on 4th October.
 


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events